Author(s): Mr. Mayur S. Jain, Dr. Shashikant D. Barhate

Email(s): mayurjain176@gmail.com

DOI: 10.5958/2231-5713.2020.00010.0   

Address: Mr. Mayur S. Jain*, Dr. Shashikant D. Barhate
Shree Sureshadada Jain Institutes of Pharmaceutical Education and Research, Jammer, Maharashtra (India).
*Corresponding Author

Published In:   Volume - 10,      Issue - 1,     Year - 2020


ABSTRACT:
Tigecycline is a glycylcycline antibiotic developed and marketed by Wyeth under the brand name Tygacil. It was developed in response to the growing prevalence of antibiotic resistance in bacteria such as Staphylococcus aureus. It was granted fast-track approval by the U.S. Food and Drug Administration (FDA) on June 17, 2005. Tigecycline is the first clinically-available drug in a new class of antibiotics called the glycylcyclines. Glycylcyclines are a new class of antibiotics derived from tetracycline. These tetracycline analogues are specifically designed to overcome two common mechanisms of tetracycline resistance, namely resistance mediated by acquired efflux pumps and/or ribosomal protection. Glycylcycline antibiotics have a similar mechanism of action as tetracycline antibiotics. Both classes of antibiotics bind to the 30S ribosomal subunit to prevent the amino-acyl tRNA from binding to the A site of the ribosome. However, the glycylcyclines appear to bind more effectively than the tetracyclines.


Keywords:

Cite this article:
Mr. Mayur S. Jain, Dr. Shashikant D. Barhate. Tigecycline is the First Clinically-Available Drug in a new class of Antibiotics called the Glycylcyclines: A Review. Asian J. Pharm. Tech. 2020; 10(1):48-50. doi: 10.5958/2231-5713.2020.00010.0


Recomonded Articles:

Author(s): Phatak Atul A., Chaudhari Praveen D.

DOI:         Access: Open Access Read More

Author(s): S. Kumara Swamy, G. Arun, Bethi Srinivas, Agaiah Goud B

DOI: 10.5958/2231-5713.2016.00014.3         Access: Open Access Read More

Author(s): Godbole Ajeet Madhukar, Patel Bhautik V, Somnache Sandesh Narayan, Prajapati Ashish R, Yadav Pradeep

DOI: 10.5958/2231-5713.2017.00004.6         Access: Open Access Read More

Author(s): M. Karthika, K. Pramod, K.C. Ajithkumar, U. S. Jijith

DOI: 10.5958/2231-5713.2016.00025.8         Access: Open Access Read More

Author(s): B. Ranga Nayakulu, Nakka Ravi Kumar, Ch. Kiran Kumar, P. Raja Abhilash

DOI: 10.5958/2231-5713.2016.00012.X         Access: Open Access Read More

Author(s): Girishchandra R., Mandake, Shital S. Shinde, Vishal Y. Belaskar, Asha M. Jagtap, Ganesh B. Vambhurkar, Manoj M. Nitalikar

DOI: 10.5958/2231-5713.2018.00033.8         Access: Closed Access Read More

Author(s): Sunil Kumar, Anil Kumar, Vaibhav Gupta, Kuldeep Malodia, Pankaj Rakha

DOI:         Access: Open Access Read More

Author(s): S. Gnanavel, R. Bharathidasan, R.mahalingam, P.Madhanraj, A. Panneerselvam

DOI:         Access: Open Access Read More

Author(s): Sushil D. Patil, Bhavini D. Chande, Kirti M. Budukhale, Radhika V. Damare, Nilam Kale, Shivangi S. Pathak

DOI: 10.5958/2231-5713.2018.00014.4         Access: Open Access Read More

Author(s): Poonam R. Songire, Smita S. Aher, R. B. Saudagar

DOI: 10.5958/2231-5713.2015.00031.8         Access: Open Access Read More

Author(s): Goli Venkateshwarlu, Ragya Eslavath, Anasuri Santhosh, Gutha Suma, J.Venkanna, Y.Swetha

DOI:         Access: Open Access Read More

Author(s): Swati Paul, Dibyajyoti Saha, Srikanta Chowdhury

DOI:         Access: Open Access Read More

Author(s): Nidhi Rao, Sandhya Mittal, Sudhanshu, Ekta Menghani

DOI:         Access: Open Access Read More

Author(s): Pawar Pravin, Yadav Adhikrao, Gharge Varsha

DOI: 10.5958/2231-5713.2018.00038.7         Access: Closed Access Read More

Asian Journal of Pharmacy and Technology (AJPTech.) is an international, peer-reviewed journal, devoted to pharmaceutical sciences...... Read more >>>

RNI: Not Available                     
DOI: 10.5958/2231–5713 


Recent Articles




Tags